These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 18790608

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 47. [Efficacy and safety of cefditoren pivoxil in treatment of respiratory infections, a clinical study].
    Li JT, Gao L, Xue F, Hao FL, Wang Q, Cai BQ, Gan CL, Liu YN, Yu BX, He LX, Hu BJ, Chen XH, Zheng JC, Yu YS, Lu FF, Liang DR, Cai YN, Kang J, Kong LF, Xiao ZL, Zheng JP, Liu J, Yang WX, Zhou J.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):391-4. PubMed ID: 12820915
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.
    Morrissey I, Ge Y, Janes R.
    Int J Antimicrob Agents; 2009 Jun 10; 33(6):515-9. PubMed ID: 19203863
    [Abstract] [Full Text] [Related]

  • 50. [Pharmacological properties and clinical efficacy of garenoxacin mesilate hydrate (Geninax Tablet 200 mg), a quinolone antimicrobial].
    Tsuda H.
    Nihon Yakurigaku Zasshi; 2008 Aug 10; 132(2):111-8. PubMed ID: 18689961
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The effect of omeprazole on the bioavailability and safety of garenoxacin in healthy volunteers.
    Krishna G, Kisicki JC, Olsen S, Grasela DM, Wang Z.
    J Clin Pharmacol; 2007 May 10; 47(5):628-32. PubMed ID: 17395892
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
    Kahn JB, Khashab M, Ambruzs M.
    Curr Med Res Opin; 2007 Jan 10; 23(1):1-7. PubMed ID: 17261234
    [Abstract] [Full Text] [Related]

  • 57. Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 2: human trials.
    Schentag JJ, Meagher AK, Forrest A.
    Ann Pharmacother; 2003 Oct 10; 37(10):1478-88. PubMed ID: 14519053
    [Abstract] [Full Text] [Related]

  • 58. The newer fluoroquinolones.
    Bolon MK.
    Infect Dis Clin North Am; 2009 Dec 10; 23(4):1027-51, x. PubMed ID: 19909896
    [Abstract] [Full Text] [Related]

  • 59. Lascufloxacin hydrochloride to treat bacterial infection.
    Thakare R, Singh S, Dasgupta A, Chopra S.
    Drugs Today (Barc); 2020 Jun 10; 56(6):365-376. PubMed ID: 32525135
    [Abstract] [Full Text] [Related]

  • 60. The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections.
    Ball P.
    Int J Antimicrob Agents; 2007 Dec 10; 30 Suppl 2():S113-7. PubMed ID: 17997283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.